Depocyte

DRUG2 trials

Sponsors

Goethe University, PETHEMA Foundation

Conditions

Acute Lymphoblastic LeukemiaAdult Acute Lymphocytic Leukemia

Phase 3

PROCEDYTE: Depocyte® Administration (Liposomal Cytarabine) as Prophylaxis of Neuromeningeal Infiltration in Acute Lymphoblastic Leukemia

TerminatedNCT00944008

PETHEMA FoundationAcute Lymphoblastic Leukemia

Start: 2009-09-30End: 2012-07-31Updated: 2015-05-08

Phase 4

German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

CompletedNCT00198978

Goethe UniversityAdult Acute Lymphocytic Leukemia

Start: 2003-01-31End: 2014-06-30Updated: 2023-03-20

Related Papers

S114: OUTCOME OF OLDER PATIENTS (>55 YRS) WITH NEWLY DIAGNOSED PH/BCR:ABL POSITIVE ALL PROSPECTIVELY TREATED ACCORDING TO PEDIATRIC-BASED, AGE-ADAPTED GMALL PROTOCOLS

HemaSphere2023-08-01

Outcome of 841 Older Patients (&gt;55 yrs) with Newly Diagnosed Ph/BCR-ABL Negative ALL Prospectively Treated According to Pediatric-Based, Age-Adapted GMALL Protocols

Blood2022-11-1516 citations

Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL.

2012-09-28342 citations